Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class (Ascending) Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
55390-0070-01 55390-0070 Vinorelbine Vinorelbine Chemotherapy Antimitotic Agent Vinca Alkaloid Feb. 11, 2004 Dec. 31, 2012 No Longer Used
00703-4402-11 00703-4402 Vincristine Sulfate Vincasar PFS 1.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous May 1, 2000 May 31, 2023 No Longer Used
00703-4412-11 00703-4412 Vincristine Sulfate Vincasar PFS 1.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous May 1, 2000 July 31, 2022 No Longer Used
00024-5824-11 00024-5824 Cabazitaxel Jevtana Chemotherapy Antimitotic Agent Taxane Intravenous June 17, 2010 In Use
00143-9204-01 00143-9204 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan. 14, 2021 In Use
00143-9205-01 00143-9205 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan. 14, 2021 In Use
00955-1020-01 00955-1020 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 21, 2010 In Use
00955-1021-04 00955-1021 Docetaxel Docetaxel 80.0 mg/4mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 21, 2010 In Use
00955-1022-08 00955-1022 Docetaxel Docetaxel 160.0 mg/8mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 23, 2016 In Use
61703-0342-09 61703-0342 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 1, 2004 In Use
61703-0342-22 61703-0342 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 1, 2004 In Use
61703-0342-50 61703-0342 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 1, 2004 In Use
00517-4300-01 00517-4300 Paclitaxel PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100.0 mg/20mL Chemotherapy Antimitotic Agent Taxane Intravenous May 2, 2023 In Use
70860-0200-05 70860-0200 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 24, 2017 Dec. 31, 2024 In Use
70860-0200-17 70860-0200 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 24, 2017 Nov. 30, 2024 In Use
70860-0200-50 70860-0200 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 24, 2017 Dec. 31, 2024 In Use
70860-0215-66 70860-0215 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Dec. 15, 2021 Sept. 30, 2024 In Use
70860-0215-67 70860-0215 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Dec. 15, 2021 Nov. 30, 2024 In Use
70860-0215-68 70860-0215 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Nov. 30, 2019 April 30, 2024 In Use
25021-0255-05 25021-0255 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb. 1, 2024 In Use
25021-0255-17 25021-0255 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb. 1, 2024 In Use
25021-0255-50 25021-0255 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb. 1, 2024 In Use
76346-0073-01 76346-0073 Mifepristone Korlym 300.0 mg/1 Hormonal Therapy Antiprogestin Cortisol Receptor Blocker Oral Feb. 17, 2012 In Use
76346-0073-02 76346-0073 Mifepristone Korlym 300.0 mg/1 Hormonal Therapy Antiprogestin Cortisol Receptor Blocker Oral Feb. 17, 2012 In Use
00591-4390-96 00591-4390 Mifepristone Mifepristone 300.0 mg/1 Hormonal Therapy Antiprogestin Cortisol Receptor Blocker Oral Jan. 19, 2024 In Use

Found 10,000 results in 9 milliseconds — Export these results